INCR InterCure Ltd: Net earnings per share growth forecast for next year

The medical cannabis sector remains stable due to strict compliance and exclusive contracts held by InterCure Ltd. (INCR). Leading positions in Israel and the EU are sustained by competent management focused on expansion. Stable cash flow secures its status as the largest distributor with an extensive pharmacy network. This chart of consensus EPS growth estimates for the coming year demonstrates market expectations, where 0.00 expresses the current value of the metric.

INCR - InterCure Ltd Projected earnings per share increase next year over the range 07/04/2022 - 11/15/2026

InterCure Ltd - analytical breakdowns and key metrics (INCR)

- share price and consensus valuation forecast:

Stock Price InterCure|INCR - Analyst Median Target

- company stock capitalization data:

Market Value INCR|INCR - Business Value

- company book value details:

Accounting Value per Share InterCure|INCR - Total Net Assets|Market Capitalization to Book Value Ratio intercure.co|INCR - Company Assets

- debt obligations and liquidity statistics:

- earnings and market ratios statistics:

INCR - Company Net Income|Future Profit InterCure Ltd.|INCR - Company Value to Net Income|Future Price to Earnings InterCure Ltd.|INCR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio InterCure|INCR - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) InterCure|INCR - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months intercure.co|INCR - Expected net earnings per share growth this year|Earnings growth forecast for next year InterCure Ltd.

- sales volume and revenue information:

INCR - Company Gross Revenue|Company Projected Revenue InterCure|INCR - Market Cap to Revenue Ratio|Forward P/S Multiple Canndoc

Comprehensive company analysis:intercure.co

InterCure Ltd. (INCR) international expansion through partnerships with European brands directly determines the future profitability of the business. This metric aggregates analysts' consensus forecasts for changes in earnings per share, measuring the year-over-year growth rates of net income. Analyzing the one-year forward EPS growth rate allows for an assessment of the company's resilience to market cycles and the risk of asset overvaluation.

Main competitors